402 related articles for article (PubMed ID: 9285089)
1. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
Friedman J; Ault K; Powchik P
Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
[No Abstract] [Full Text] [Related]
2. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
[TBL] [Abstract][Full Text] [Related]
3. [Weight gain and clozapine].
Jalenques I; Tauveron I; Albuisson E; Audy V
Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282
[No Abstract] [Full Text] [Related]
4. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
Raskin S; Katz G; Zislin Z; Knobler HY; Durst R
Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
Zink M; Kuwilsky A; Krumm B; Dressing H
J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
Taylor DM; Smith L
Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
[TBL] [Abstract][Full Text] [Related]
7. [Resistant schizophrenia: what chemotherapy?].
Vanelle JM
Ann Med Psychol (Paris); 1993 Apr; 151(4):346-51. PubMed ID: 7904434
[No Abstract] [Full Text] [Related]
8. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
Stengler-Wenzke K
Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
[TBL] [Abstract][Full Text] [Related]
9. Clozapine augmented with aripiprazole in 5 patients with schizophrenia.
Abu-Tair F; Kopitz J; Bergemann N
J Clin Psychopharmacol; 2006 Dec; 26(6):669-71. PubMed ID: 17110831
[No Abstract] [Full Text] [Related]
10. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
11. Management of treatment refractory schizophrenia.
Morrison DP
Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
[No Abstract] [Full Text] [Related]
12. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
[No Abstract] [Full Text] [Related]
13. Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.
Lerma-Carrillo I; Molina JD; Cuevas-Durán T; González-Parra S; Blasco-Fontecilla H; Andrade-Rosa C; López-Muñoz F; Alamo C
Clin Neuropharmacol; 2007; 30(2):114-21. PubMed ID: 17414944
[TBL] [Abstract][Full Text] [Related]
14. Simple schizophrenia in an adolescent.
Valentí M; Castro-Fornieles J; Lázaro ML; Sugrañes G; Baeza I
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):589-90. PubMed ID: 19877985
[No Abstract] [Full Text] [Related]
15. Clozapine therapy raises serum concentrations of high sensitive C-reactive protein in schizophrenic patients.
Löffler S; Löffler-Ensgraber M; Fehsel K; Klimke A
Int Clin Psychopharmacol; 2010 Mar; 25(2):101-6. PubMed ID: 20101184
[TBL] [Abstract][Full Text] [Related]
16. [Clozapine and treatment of negative symptoms].
Lançon C; Farisse J; Llorca PM
Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
[TBL] [Abstract][Full Text] [Related]
17. Clozapine maintenance therapy in schizophrenia.
Gaszner P; Makkos Z
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
[TBL] [Abstract][Full Text] [Related]
18. The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
Thompson PA; Buckley PF; Meltzer HY
J Clin Psychopharmacol; 1994 Oct; 14(5):344-6. PubMed ID: 7806691
[TBL] [Abstract][Full Text] [Related]
19. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia.
Kim JH; Kim SY; Ahn YM; Kim YS
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):301-5. PubMed ID: 16309807
[TBL] [Abstract][Full Text] [Related]
20. [Neuroleptic modification of basic schizophrenic disorders].
Heim M; Morgner J
Psychiatr Neurol Med Psychol (Leipz); 1987 May; 39(5):274-80. PubMed ID: 2888144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]